Do Diabetic Foot Infections With Methicillin-Resistant Staphylococcus aureus Differ From Those With Other Pathogens?

被引:53
|
作者
Zenelaj, Besa [1 ,2 ]
Bouvet, Cindy [1 ,2 ]
Lipsky, Benjamin A. [1 ,2 ,3 ]
Uckay, Ilker [1 ,2 ]
机构
[1] Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland
[2] Fac Med, Geneva, Switzerland
[3] Univ Oxford, Oxford, England
来源
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS | 2014年 / 13卷 / 04期
关键词
diabetic foot infection; Staphylococcus aureus; MRSA; review; treatment; RISK-FACTORS; SOFT-TISSUE; MICROBIAL PROFILE; CLINICAL-OUTCOMES; TREATMENT FAILURE; COMPLICATED SKIN; ULCERS; VANCOMYCIN; OSTEOMYELITIS; PREVALENCE;
D O I
10.1177/1534734614550311
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
There is controversy as to whether or not diabetic foot infections (DFIs) caused by methicillin-resistant Staphylococcus aureus (MRSA) are associated with worse outcomes than DFIs caused by other pathogens. To address this issue we performed a nonsystematic literature search of published articles in English language journals seeking studies reporting on the outcomes of DFIs related to their microbiology. We retrieved 48 articles published from 1999 to 2013 that described a total of 7771 cases of DFI. The overall proportion of DFIs with an isolate of S aureus was about 30%; just over one third of these (11% of all cases) were MRSA strains. Among the DFI cases caused by MRSA 1543 were episodes of soft tissue infections and 113 of osteomyelitis, while non-MRSA organisms caused 5761 soft tissue infections and 354 cases of osteomyelitis. Only 5 of the included articles attempted a comparison between DFI caused by MRSA and those caused by other pathogens, with no clear differences noted. The median total duration of antibiotic therapy for DFI caused by MRSA was 26 days, of which a median of 10 days was given intravenously. Only a few articles reported the proportion of patients with a recurrence, but they often did not differentiate between MRSA and non-MRSA cases. Four publications reported a worse functional or microbiological outcome in MRSA, compared to non-MRSA, cases, but the findings were variable and differences did not seem to be significant. Many trials failed to adjust for case-mix or to definitively demonstrate a relationship between microbiology and outcomes. Few of the articles specifically commented on whether the MRSA isolates were health care- or community-acquired strains. Notwithstanding the substantial limitations of the available literature, there does not appear to be a need for any special treatment for DFI caused by MRSA. The current guidelines for treating according to established international recommendations seem appropriate.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 50 条
  • [1] Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections
    Eleftheriadou, Loanna
    Tentolouris, Nicholas
    Argiana, Vasiliki
    Jude, Edward
    Boulton, Andrew J.
    DRUGS, 2010, 70 (14) : 1785 - 1797
  • [2] Infections of Diabetic Foot Ulcers With Methicillin-Resistant Staphylococcus aureus
    Cervantes-Garcia, Estrella
    Garcia-Gonzalez, Rafael
    Resendiz-Albor, Aldo
    Maria Salazar-Schettino, Paz
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2015, 14 (01): : 44 - 49
  • [3] Daptomycin for Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections
    Joseph, Warren S.
    Quast, Thomas
    Cogo, Alberto
    Crompton, Monica G.
    Yoon, Min Jung
    Lamp, Kenneth C.
    Culshaw, Darren
    Chaves, Ricardo L.
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2014, 104 (02) : 159 - 168
  • [4] Methicillin-Resistant Staphylococcus Aureus Infections
    Taylor, Abraham R.
    PRIMARY CARE, 2013, 40 (03): : 637 - +
  • [5] The Clinical Value of Methicillin-Resistant Staphylococcus aureus Nasal Screening in the Management of Diabetic Foot Infections
    Hosry, Jeff
    Wang, Taylor
    Assaad, Marc
    Kamel, Ralph
    Homsy, Sylvester
    Sleiman, Elsa
    Glaser, Allison
    Mobarakai, Neville K.
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2022,
  • [6] Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections
    Lavery, Lawrence A.
    La Fontaine, Javier
    Bhavan, Kavita
    Kim, Paul J.
    Williams, Jayme R.
    Hunt, Nathan A.
    DIABETIC FOOT & ANKLE, 2014, 5 (01):
  • [7] Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus
    Ambrosch, Andreas
    Haefner, Simone
    Jude, Edward
    Lobmann, Ralf
    INTERNATIONAL WOUND JOURNAL, 2011, 8 (06) : 567 - 577
  • [8] Management of methicillin-resistant Staphylococcus aureus infections
    Garau, J.
    Bouza, E.
    Chastre, J.
    Gudiol, F.
    Harbarth, S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (02) : 125 - 136
  • [9] Methicillin-resistant Staphylococcus aureus infections
    Barry M. Farr
    Current Infectious Disease Reports, 1999, 1 (4) : 328 - 333
  • [10] Methicillin-Resistant Staphylococcus aureus Infections
    Pottinger, Paul S.
    MEDICAL CLINICS OF NORTH AMERICA, 2013, 97 (04) : 601 - +